Clinical research: a view from the north of Brazil
DOI:
https://doi.org/10.33448/rsd-v10i16.23175Keywords:
Clinical protocols; Clinical trial; Regional development; Neglected diseases.Abstract
Clinical research is important for understanding pathologies and discovering therapeutic innovations. In Brazil, although it is expanding and has aroused interest in researchers and institutions, especially in this period of the COVID-19 pandemic, it is still characterized as a new area, and in many regions of the country there is a lack of research that prioritizes the demand for diseases of national importance. Thus, the aim of this study was to map clinical research centers in addition to studies on this topic, focusing on the northern region of Brazil. The study was carried out by searching the database of the CNPQ Directory of Research Groups, Brazil Platform, National Health Surveillance Agency, National Network of Clinical Research, Brazilian Registry of Clinical Trials and ClinicalTrials.gov. The North region, although having relevant centers, these in number are inferior to other regions of Brazil. Likewise, in the state of Tocantins, clinical studies are still a modest reality. In this sense, the need for an equal distribution of research centers in the country and investments in clinical studies, especially in Tocantins is highlighted, as there are several demands in the national territory due to regional differences in the population and potential of each location.
References
Brasil. Departamento de Ciência e Tecnologia, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Ministério da Saúde. (2010). National clinical research network: Brazilian response and mitigation of international dependency. Rev Saude Publica., 44, 575–578.
Brasil. Ministério da Saúde. (2018). Brasil institui o Plano de Ação de Pesquisa Clínica para aumentar competitividade no país. Recovered from https://www.saude.gov.br/noticias/sctie/42825-brasil-institui-o-plano-de-acao-de-pesquisa-clinica-para-aumentar-competitividade-no-pais
Brasil. Ministério da saúde. (2020). Plano de ação de pesquisa clínica no Brasil.
Brasil. Ministério da saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. (2010). Rede Nacional de Pesquisa Clínica. Brasília: Ministério da Saúde.
Brasil. Secretaria de Ciência T e IE. Rede Nacional de Pesquisa Clínica [Folder]. 2010. Recovered from https://rute.rnp.br/web/sig-rede-nacional-de-pesquisa-clinica-rnpc
Brasil. (2018). Consolidado de normas de registro e notificação de fitoterápicos. Agencia Nac Vigiância Sanitária., 1–655.
Cardoso, F., Rebelo, F. (2019). A importância da pesquisa clínica para o Brasil. Assoc da Indústria Farm Pesqui., 1, 1–52.
Centros de Bioequivalência e Biodisponibilidade - Anvisa. (2020). Recovered from http://portal.anvisa.gov.br/centros-de-bioequivalencia-e-biodisponibilidade
CEPEM. (2020). Recovered from https://sites.google.com/site/cepemipepatro/
Consulta de Ensaios Clínicos Autorizados pela Anvisa. (2020). Recovered from http://www7.anvisa.gov.br/Datavisa/Consulta_Comunicados/Consulta_CE_Autorizados.asp
Dainesi, S. M., Goldbaum, M. (2012). Pesquisa clínica como estratégia de desenvolvimento em saúde. Rev Assoc Med Bras., 58, 2–6.
Diniz, M. B., Diniz, M. J. T. (2018). Exploração dos recursos da biodiversidade da Amazônia Legal: uma avaliação com base na abordagem do Sistema Nacional/Regional de Inovação. Redes., 23, 210.
Diretório de Grupos de Pesquisa - Plataforma Lattes - CNPq. (2020). Recovered from http://lattes.cnpq.br/web/dgp
Empresa Brasileira de Pesquisa Agropecuária. (2016, novembro).
Santana, I. (2016). Potencial farmacológico de espécies da Amazônia é tema de palestra no IV CBRG. Recovered from https://www.embrapa.br/busca-de-noticias/-/noticia/18162156/potencial-farmacologico-de-especies-da-amazonia-e-tema-de-palestra-no-iv-cbrg
Home - ClinicalTrials.gov. (2020). Recovered from https://clinicaltrials.gov/ct2/home
Instituto de Pesquisa Clínica Carlos Borborema Amazonas. (2020). Recovered from https://www.ipccb.org/
Klein, V. P. (2017). Invisibilidade da Pesquisa Clínica no Brasil : considerações a partir de fontes de informação em Ciência & Tecnologia. Rev Eletron Comum Inf Inov Saúde, 11, 1–9.
Marcon, J. L., Menin, M., Araújo, M. G. P., Hrbek, T. (2012). Biodiversidade Amazônica: caracterização, ecologia e conservação.
Rede Fiocruz de Pesquisa Clínica - Fundação Oswaldo Cruz (Fiocruz): Ciência e tecnologia em saúde para a população brasileira. (2020). Recovered from https://portal.fiocruz.br/rede-fiocruz-de-pesquisa-clinica-rfpc
Registro Brasileiro de Ensaios Clínicos. (2020). Recovered from http://www.ensaiosclinicos.gov.br/
Silveira, C., Barros, A., Rau, C. (2016). Evolução Da Pesquisa Clínica Nacional E Das Medidas De Regulação Pelos Conselhos De Ética E Anvisa. Recovered from http://www.cpgls.pucgoias.edu.br/7mostra/Artigos/SAUDE E BIOLOGICAS/EVOLUÇÃO DA PESQUISA CLÍNICA NACIONAL.pdf
Zucchetti, C., Morrone, F. B. (2012). Perfil da pesquisa clínica no Brasil. Clin Biomed Res., 32, 340–347.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Andreia Travassos; Dafne Nayara Quinta Barbosa; Rhaissa Calazans Lameira da Silva; Guilherme Nobre L. do Nascimento
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.